Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Assets (2016 - 2025)

Historic Assets for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $36.1 billion.

  • Fresenius Medical Care AG's Assets rose 113.26% to $36.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 billion, marking a year-over-year increase of 113.26%. This contributed to the annual value of $35.9 billion for FY2024, which is 174.64% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Assets stood at $36.1 billion, which was up 113.26% from $35.4 billion recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Assets peaked at $40.0 billion during Q1 2021, and registered a low of $58.0 million during Q4 2021.
  • In the last 5 years, Fresenius Medical Care AG's Assets had a median value of $37.3 billion in 2024 and averaged $35.5 billion.
  • Its Assets has fluctuated over the past 5 years, first crashed by 7420.66% in 2021, then surged by 6281995.2% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Assets (Quarter) stood at $58.0 million in 2021, then surged by 62819.95% to $36.5 billion in 2022, then rose by 0.08% to $36.5 billion in 2023, then fell by 1.75% to $35.9 billion in 2024, then increased by 0.67% to $36.1 billion in 2025.
  • Its Assets was $36.1 billion in Q3 2025, compared to $35.4 billion in Q2 2025 and $34.4 billion in Q1 2025.